MVMen’s Vitality
Bulletin
A clearer view of men’s health ↗
Vitamins & Minerals / EVIDENCE GUIDE

The MOXI trial: a seven-ingredient antioxidant blend did not improve live birth

In a multicenter randomized trial, antioxidant supplementation did not improve semen measures, pregnancy, or live birth in male-factor infertility.

Organic home-grown tomatoes arranged in a circle. Christchurch, New Zealand.
Organic home-grown tomatoes - unripe to ripe · Michal Klajban · CC BY-SA 4.0 · Source · License
THE KEY TAKEAWAY

The MOXI trial found no fertility advantage from a multi-antioxidant supplement and cautions against assuming that more antioxidants improve conception.

The trial measured the outcome couples care about

Male-fertility supplements frequently advertise changes in sperm concentration, motility, morphology, or DNA fragmentation. Those laboratory measures can be useful, but they do not guarantee pregnancy or live birth. The MOXI trial included live birth as its primary clinical outcome.

The multicenter double-blind placebo-controlled design enrolled couples with male-factor infertility and documented key female-partner eligibility. That helps connect the supplement question to real conception outcomes rather than a single semen test.

Sunflower seeds.
Sunflower seeds. img 009 · Dmitry Makeev · CC BY-SA 4.0 · Source · License

The formula contained seven components

Men were randomized to placebo or a daily combination containing vitamin C, vitamin E, selenium, L-carnitine, zinc, folic acid, and lycopene. Treatment lasted three to six months while couples attempted natural conception and later followed a specified insemination protocol.

Because the intervention was a blend, the trial tested the complete formula. It cannot determine whether an individual ingredient had a small opposing or favorable effect. It can answer whether this combined strategy improved the prespecified outcomes under the protocol.

Semen and DNA outcomes did not improve

After three months, the groups did not differ significantly in motility, morphology, or sperm DNA fragmentation. Sperm concentration did not improve with the antioxidants and differed in an unfavorable direction in the overall comparison.

These findings challenge the assumption that antioxidant labels necessarily reduce oxidative damage in a way visible on semen testing. Biological plausibility does not guarantee a net benefit from a multi-ingredient dose.

Air displacement pipette 10-200 mkl with packaging, manufactured by scientific production association Biopribor (Russia)
A laboratory micropipette shown as research context; this is not a photograph from the MOXI trial. · Ivan Pchelin · CC0 · Source · License

Pregnancy and live birth also did not improve

Cumulative live birth was 15 percent in the antioxidant group and 24 percent in the placebo group, without a statistically significant treatment benefit. The trial was limited by sample size and stopped after its internal-pilot assessment, so it was not designed to prove that antioxidants can never help any subgroup.

It does provide direct randomized evidence against assuming that this common blend improves fertility outcomes. A null clinical result should be presented alongside any smaller study showing a favorable semen marker.

High-dose components still have safety context

The formula included 400 milligrams of vitamin E. Updated NIH guidance notes that high-dose supplemental vitamin E can increase bleeding risk and interact with anticoagulant or antiplatelet medicines. Other components can overlap with multivitamins and fertility products.

This guide does not recommend copying or avoiding a regimen without individualized advice. Male-factor infertility deserves evaluation of both partners and the underlying cause. MOXI's practical lesson is that a large antioxidant stack is not automatically beneficial, and live-birth evidence matters more than an antioxidant story.

Oxidation and reduction are normal biological processes, and reactive molecules participate in sperm signaling. Suppressing oxidation broadly does not guarantee better reproductive function. Effects may depend on baseline oxidative stress, nutrient status, dose, timing, and the balance among ingredients.

Because MOXI tested a combination, it cannot prove that every individual nutrient is ineffective in every deficient person. It does show that giving the complete high-dose formula to the enrolled population did not improve semen, pregnancy, or live-birth outcomes compared with placebo.

That distinction supports targeted care. A documented deficiency can be treated for established reasons, while unexplained infertility needs diagnosis rather than an automatic antioxidant stack. Future trials should stratify baseline status, publish all outcomes, and focus on live birth instead of selecting a favorable laboratory marker.

The formula also reached or approached amounts that can overlap substantially with other supplements. Users may already receive zinc, folic acid, selenium, vitamins C and E, or carnitine from a multivitamin or fertility blend. Counting total exposure matters because nutrients can cause harm or interactions at high intakes. A failed efficacy trial does not mean the ingredients are inert, and lack of benefit is not permission to escalate the dose.

MOXI's limitations should remain visible: enrollment was smaller than a definitive live-birth trial, and stopping after the internal pilot reduced precision. Still, the absence of improvement across semen, DNA-fragmentation, pregnancy, and live-birth outcomes makes the result clinically important. A smaller favorable biomarker study should not be presented without this more direct randomized evidence.

Sources & further reading

  1. MOXI randomized clinical trial of antioxidants for male-factor infertility ↗
  2. Dietary supplements and male infertility: 2025 systematic review ↗
  3. NIH ODS: Vitamin E health professional fact sheet ↗

This article provides educational information. Ask a qualified clinician or pharmacist about your symptoms, medical conditions, medicines and supplement interactions.

More on Vitamins & Minerals →